Health Care & Life Sciences » Pharmaceuticals | YiChang HEC ChangJiang Pharmaceutical Co. Ltd.

YiChang HEC ChangJiang Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
88,547.40
205,285.00
388,183.80
529,370.70
-
1,306
Depreciation, Depletion & Amortization
37,306.50
40,203.70
29,375.30
29,814.50
-
72
Other Funds
77,631.00
218,834.40
37,116.70
-
-
220
Funds from Operations
89,043.20
200,696.40
389,054.60
468,303.30
785,360.60
1,158
Changes in Working Capital
85,788.00
90,551.20
62,959.30
3,441.00
-
295
Net Operating Cash Flow
3,255.20
110,145.20
326,095.30
464,862.30
785,360.60
863
Capital Expenditures
96,443.20
44,640.00
34,542.40
202,121.20
427,501.20
Sale of Fixed Assets & Businesses
4,172.50
91.90
6,484.40
-
423.20
Purchase/Sale of Investments
-
-
40,704.90
236,985.70
137,595.60
Net Investing Cash Flow
92,270.70
48,557.80
426,472.20
439,106.90
723,110.00
Cash Dividends Paid - Total
-
-
-
79,012.00
364,855.10
Issuance/Reduction of Debt, Net
168,073.50
212,225.80
271,365.70
122,683.90
80,716.10
Net Financing Cash Flow
90,442.50
6,608.50
1,663,316.60
225,708.10
423,265.90
Net Change in Cash
1,427.00
68,195.90
1,562,939.70
165,423.50
374,625.20
Free Cash Flow
93,188.00
65,505.20
291,552.90
391,267.10
408,259.60
Net Assets from Acquisitions
-
4,009.70
-
-
158,436.40
Change in Capital Stock
-
-
1,971,799.00
24,012.20
22,305.30
Exchange Rate Effect
-
-
-
34,529.10
13,609.90
Other Uses
-
-
357,709.40
-
-

About YiChang HEC ChangJiang Pharmaceutical Co.

View Profile
Address
Dong YangGuang Park
Dongguan Guangdong 443300
China
Employees -
Website http://www.hec-changjiang.com
Updated 07/08/2019
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. engages in the development, manufacturing and selling of pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, cardiovascular diseases and others. Its products include Benzbromarone, Telmisartan, Amlodipine besylate, and Cetirizine hydrochloride. The company was founded on May 11, 2015 and is headquartered in Dongguan, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.